Skip to main content
Harold Burstein, MD, Oncology, Boston, MA

HaroldJohnBursteinMD

Oncology Boston, MA

Breast Cancer, Hematologic Oncology

Associate Professor of Medicine, Dana-Farber Cancer Institute

Dr. Burstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Burstein's full profile

Already have an account?

  • Office

    44 Binney St
    # Dana
    Boston, MA 02115
    Phone+1 617-632-2624
    Fax+1 617-632-1930

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1996
  • Harvard Medical School
    Harvard Medical SchoolClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • RI State Medical License
    RI State Medical License 2022 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 1996 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Boston Magazine Castle Connolly, 2008, 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adjuvant Capecitabine in Triple-Negative Breast Cancer  
    Harold Burstein, MD, JAMA
  • Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer  
    Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Lectures

  • Genomic Profiling in ER-Positive Breast Cancer, From MINDACT to TAILORx 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Breast Cancer, New Horizons, Current Controversies 
    Harvard Medical School, Boston, Massachusetts - 7/11/2013
  • The New York Metropolitan Breast Cancer Group 40th Annual Symposium: Breast Cancer 2013 
    The New York Academy of Medicine, New York, New York - 2/2/2013
  • Join now to see all

Press Mentions

  • Homing in on Anthracyclines' High-Risk Niche in Early Breast Cancer
    Homing in on Anthracyclines' High-Risk Niche in Early Breast CancerDecember 14th, 2024
  • Oral SERD Impresses in Advanced Breast Cancer with ESR1 Mutations
    Oral SERD Impresses in Advanced Breast Cancer with ESR1 MutationsDecember 11th, 2024
  • Small Benefit, Persistent Toxic Risk with Adjuvant Anthracycline in Breast Cancer
    Small Benefit, Persistent Toxic Risk with Adjuvant Anthracycline in Breast CancerNovember 19th, 2024
  • Join now to see all

Professional Memberships